News | March 23, 2023
Emmes acquires Essex Management
Essex enriches and complements Emmes’ services
Essex enriches and complements Emmes’ services
Proposed combination enhances Pfizer’s position as a leading company in oncology
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Natural Capsules Limited's shareholding will be reduced to 89.99%
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Agasta Software is engaged in research, development and commercialization of medical devices
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Subscribe To Our Newsletter & Stay Updated
